A trial of mesenchymal stem cell is planned for the end of 2010.
Since April 2000 the mission of the HDLighthouse Families Web site is to present and explain the latest research findings so that families afflicted by Huntington's disease can become proactive in their care, have hope for the future, and make good decisions in the present. Additionally we provide information that is vital to the the support of HD families. Where possible we will direct you to specialists in the your area of concern, but if we are able to provide better or more current information then you'll find it here.
Preclinical work supports the use of mesenchymal stem cells to treat neurodegenerative disorders.
A new BDNF inducer enters the pipeline.
Clear differences were found among the control group, premanifest gene carriers, and those in early stages.
The search for genetic modifiers is an important part of the effort to find treatments.
Overexpression of the RCAN1 gene may be a treatment for Huntington's Disease.
Researchers have identified the mechanism by which axonal transport is impaired in neurons in HD.